GW Pharmaceuticals to Present at the Leerink Partners 6th Annual Global Healthcare Conference on 15 February

LONDON, Feb. 08, 2017 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced that Justin Gover, GW’s Chief Executive Officer, will present at the Leerink Partners 6th Annual Global Healthcare Conference on Wednesday, February 15, 2017 at 2:00 p.m. EST at the Lotte New York Palace, New York City.  

A live audio webcast of the presentation will be available through GW’s corporate website at www.gwpharm.com in the Investors section under Events Presentations. A replay will be available soon after the live presentation.

About GW Pharmaceuticals plc

Founded in 1998, GW is a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform in

... read more at: http://www.nasdaq.com/press-release/gw-pharmaceuticals-to-present-at-the-leerink-partners-6th-annual-global-healthcare-conference-on-1-20170208-01104

by